Novo Holdings A/S - Q4 2013 holdings

Add to watchlist

$1.34 Billion is the total value of Novo Holdings A/S's 12 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 60.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
VTI BuyVANGUARD INDEX FDStotal stk mkt$571,510,000
+118.9%
5,958,200
+100.0%
42.64%
-34.1%
OPHT NewOPHTHOTECH CORP$446,666,000–13,807,308
+100.0%
33.33%–
VGK BuyVANGUARD INTL EQUITY INDEX Fftse europe etf$247,078,000
+115.8%
4,202,000
+100.0%
18.44%
-35.0%
PTCT BuyPTC THERAPEUTICS INC$22,956,000
+104.8%
1,194,718
+59.9%
1.71%
-38.3%
T107PS  WRIGHT MED GROUP INC$17,989,000
+17.8%
585,7590.0%1.34%
-64.5%
TTPH NewTETRAPHASE PHARMACEUTICALS INC$16,224,000–1,200,000
+100.0%
1.21%–
NewTETRAPHASE PHARMACEUTICALS INC$16,224,000–1,200,000
+100.0%
1.21%–
WMGIZ  WRIGHT MED GROUP INCright 03/01/2019$1,525,000
-9.0%
4,720,0650.0%0.11%
-72.5%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2014-11-14
  • View 13F-HR filed 2014-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VANGUARD INDEX FDS41Q3 202264.7%
INOGEN INC34Q2 202268.8%
VANGUARD INTL EQUITY INDEX F29Q4 201637.6%
AMICUS THERAPEUTICS INC22Q3 20234.1%
AKEBIA THERAPEUTICS INC21Q3 20204.8%
VERONA PHARMA PLC21Q2 20221.9%
CORVUS PHARMACEUTICALS INC20Q4 20207.1%
INSPIRE MED SYS INC20Q3 20231.8%
CABLE ONE INC19Q3 20239.7%
FLEXION THERAPEUTICS INC19Q3 20214.7%

View Novo Holdings A/S's complete holdings history.

Latest significant ownerships (13-D/G)
Novo Holdings A/S Q4 2013 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cyteir Therapeutics, Inc.August 03, 20231,547,1364.4%
Disc Medicine, Inc.June 28, 20231,090,7724.8%
Galera Therapeutics, Inc.June 28, 20232,100,0004.9%
VectivBio Holding AGSold outMay 26, 202300.0%
LanzaTech Global, Inc.February 17, 202315,814,8458.1%
Bolt Biotherapeutics, Inc.Sold outJanuary 04, 202300.0%
Arcellx, Inc.December 12, 20221,750,0004.0%
MINERVA SURGICAL INCNovember 03, 20221,322,4734.5%
Milestone Pharmaceuticals Inc.October 24, 20221,378,5384.6%
Galecto, Inc.September 30, 20222,497,7919.8%

View Novo Holdings A/S's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D/A2024-03-28
42024-03-25
SC 13D/A2024-03-25
42024-03-20
SC 13D/A2024-03-20
1442024-03-18
42024-03-18
SC 13D/A2024-03-18
1442024-03-14
SC 13D/A2024-03-07

View Novo Holdings A/S's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1340173000.0 != 1340172000.0)
  • The reported has been amended

Export Novo Holdings A/S's holdings

CSVXLS